Author: Branwen Brockley
-
Gilbertson Group receive £5.8m to find new treatments for brain tumours in children
Researchers at the Institute are set to receive over £5.8 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat brain tumours in children.
Find out more -
Fanni Gergely elected to EMBO Membership
Dr Fanni Gergely, Senior Group Leader at the Institute, has been elected as a member of the European Molecular Biology Organisation (EMBO) in recognition of her high quality life science research.
Find out more -
Dr Giulia Biffi joins Institute as new Group Leader
Dr Giulia Biffi is joining the Cancer Research UK Cambridge Institute as a new Group Leader in January 2020.
Find out more -
Dr Stockis awarded Marie Curie Fellowship to investigate immune cell communication
Dr Julie Stockis, Halim Group, has been awarded a prestigious Marie Skłodowska-Curie Fellowship.
Find out more -
Identifying active targets in hard to treat cancers
Dr Geoff Macintyre and Dr Anna Piskorz have received a Cancer Research UK Innovation Prize to develop a test that could identify active therapeutic targets in hard to treat cancers.
Find out more -
Efficient “on demand” generation of complex mouse models
Dr Alasdair Russell and Dr Liam Cassidy have been awarded a Cancer Research UK Pioneer Award to develop an innovative genetic barcoding technology to generate complex mouse models.
Find out more -
Light Microscopy Image Contest 2019
Each year, our Light Microscopy Core Facility runs an Image Contest, showcasing the breadth and beauty of the research in the building.
Find out more -
Molecular patterns could better predict breast cancer recurrence
The genetic and molecular make-up of individual breast tumours holds clues to how a woman’s disease could progress, including the likelihood of it coming back after treatment, and in what time frame.
Find out more -
Establishing the molecular blueprint of early embryo development
A pioneering group of biologists, physicists and mathematical modellers in Cambridge have studied the genetic activity of over 100,000 embryonic cells to establish the molecular blueprint of mouse early embryo development.
Find out more